Selective vasodilator effect of magnesium sulfate in human placenta (Q44946112)

7 December 2017

Selective vasodilator effect of magnesium sulfate in human placenta (English)

1 reference

7 December 2017

0 references

0 references

1 reference

Gershon Holcberg

1

1 reference

7 December 2017

Olga Sapir

2

1 reference

7 December 2017

Mordechai Hallak

3

1 reference

7 December 2017

Amash Alaa

4

1 reference

7 December 2017

Haj-Yhia Shorok

5

1 reference

7 December 2017

Yohay David

6

1 reference

7 December 2017

Miriam Katz

7

1 reference

7 December 2017

Mahmoud Huleihel

8

1 reference

7 December 2017

1 March 2004

1 reference

American Journal of Reproductive Immunology

7 December 2017

1 reference

7 December 2017

51

1 reference

7 December 2017

3

1 reference

7 December 2017

192-197

1 reference

Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate.

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

The effects of magnesium sulfate therapy on Apgar scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

The effects of intrapartum magnesium sulfate therapy on fetal serum interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha at delivery: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Preeclampsia: an imbalance in placental prostacyclin and thromboxane production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Tumor necrosis factor in preterm and term labor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: The effect of gestational age, fetal gender, and intrauterine infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Pressor response to angiotonin in pregnant and nonpregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Sensitization of the vascular system in pre-eclamptic toxaemia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

Effect of low-dose aspirin on angiotensin II pressor response in human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2004.00115.X

10.1111/J.1600-0897.2004.00115.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference